l-α-aminoadipate causes astrocyte pathology with negative impact on mouse hippocampal synaptic plasticity and memory

FASEB J. 2021 Aug;35(8):e21726. doi: 10.1096/fj.202100336R.

Abstract

Increasing evidence shows that astrocytes, by releasing and uptaking neuroactive molecules, regulate synaptic plasticity, considered the neurophysiological basis of memory. This study investigated the impact of l-α-aminoadipate (l-AA) on astrocytes which sense and respond to stimuli at the synaptic level and modulate hippocampal long-term potentiation (LTP) and memory. l-AA selectivity toward astrocytes was proposed in the early 70's and further tested in different systems. Although it has been used for impairing the astrocytic function, its effects appear to be variable in different brain regions. To test the effects of l-AA in the hippocampus of male C57Bl/6 mice we performed two different treatments (ex vivo and in vivo) and took advantage of other compounds that were reported to affect astrocytes. l-AA superfusion did not affect the basal synaptic transmission but decreased LTP magnitude. Likewise, trifluoroacetate and dihydrokainate decreased LTP magnitude and occluded the effect of l-AA on synaptic plasticity, confirming l-AA selectivity. l-AA superfusion altered astrocyte morphology, increasing the length and complexity of their processes. In vivo, l-AA intracerebroventricular injection not only reduced the astrocytic markers but also LTP magnitude and impaired hippocampal-dependent memory in mice. Interestingly, d-serine administration recovered hippocampal LTP reduction triggered by l-AA (2 h exposure in hippocampal slices), whereas in mice injected with l-AA, the superfusion of d-serine did not fully rescue LTP magnitude. Overall, these data show that both l-AA treatments affect astrocytes differently, astrocytic activation or loss, with similar negative outcomes on hippocampal LTP, implying that opposite astrocytic adaptive alterations are equally detrimental for synaptic plasticity.

Keywords: astrocyte; hippocampus; l-α-aminoadipate; memory; synaptic plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Aminoadipic Acid / administration & dosage
  • 2-Aminoadipic Acid / antagonists & inhibitors
  • 2-Aminoadipic Acid / toxicity*
  • Adenosine Triphosphate / metabolism
  • Animals
  • Astrocytes / drug effects*
  • Astrocytes / pathology
  • Astrocytes / physiology
  • Cells, Cultured
  • Excitatory Amino Acid Antagonists / administration & dosage
  • Excitatory Amino Acid Antagonists / toxicity
  • Glial Fibrillary Acidic Protein / metabolism
  • Glutamic Acid / metabolism
  • Hippocampus / drug effects*
  • Hippocampus / pathology
  • Hippocampus / physiopathology*
  • In Vitro Techniques
  • Injections, Intraventricular
  • Long-Term Potentiation / drug effects
  • Long-Term Potentiation / physiology
  • Male
  • Memory / drug effects
  • Memory / physiology
  • Mice
  • Mice, Inbred C57BL
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / physiology
  • Serine / administration & dosage
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology

Substances

  • Excitatory Amino Acid Antagonists
  • Glial Fibrillary Acidic Protein
  • glial fibrillary astrocytic protein, mouse
  • 2-Aminoadipic Acid
  • Glutamic Acid
  • Serine
  • Adenosine Triphosphate